EUVIMEDSkopri EUVIMED
Übersichtsarbeit

Harmonizing HTA Evidence Needs and Expectations: Challenges and Opportunities to Improve Evidence Generation, Ensure Access and Affordability

Sarah K Emond, Wim G Goettsch, Daniel A Ollendorf iD

Clinical Pharmacology & Therapeutics · 2025

DOI: 10.1002/cpt.3579 ↗

At a glance

Übersichtsarbeit in Clinical Pharmacology & Therapeutics, 2025. Written by Sarah K Emond and 2 co-authors. Institution: Institute for Clinical and Economic Review, Boston, Massachusetts, USA. Major MEDLINE topics: Technology Assessment, Biomedical, Health Services Accessibility, Evidence-Based Medicine. Cited 4 times so far (Crossref); 60 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Conducting high‐quality health technology assessments requires high‐quality evidence. With evolving regulatory standards for faster approval of new pharmaceutical products, health technology practitioners often find that the evidence base available to inform their work is lacking. This review article provides case examples of how health technology assessors have grappled with this tension, from the United States and European perspective, including experiences with new therapies for large populations, such as Alzheimer's disease, and gene therapies for ultra‐rare conditions. The article concludes by offering some potential policy solutions that can meet the goals of robust evidence generation, patient access, and system affordability, including reimbursement with evidence development, outcomes‐based contracts, and other types of managed entry agreements.

Subjects

MeSH terms (MEDLINE)

Technology Assessment, BiomedicalHealth Services AccessibilityEvidence-Based MedicineHumansUnited StatesEurope

Authors and institutions

  • Institute for Clinical and Economic Review, Boston, Massachusetts, USA.
  • Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands.
  • National Health Care Institute, Diemen, The Netherlands.
  • Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, Massachusetts, USA.

ORCID profiles: Daniel A Ollendorf

Cite

APA

Emond, S. K., Goettsch, W. G., & Ollendorf, D. A. (2025). Harmonizing HTA Evidence Needs and Expectations: Challenges and Opportunities to Improve Evidence Generation, Ensure Access and Affordability. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.3579

Vancouver

Emond SK, Goettsch WG, Ollendorf DA. Harmonizing HTA Evidence Needs and Expectations: Challenges and Opportunities to Improve Evidence Generation, Ensure Access and Affordability. Clinical Pharmacology & Therapeutics. 2025. doi:10.1002/cpt.3579

BibTeX
@article{Emond2025,
  author = {Emond, Sarah K and Goettsch, Wim G and Ollendorf, Daniel A},
  title = {Harmonizing HTA Evidence Needs and Expectations: Challenges and Opportunities to Improve Evidence Generation, Ensure Access and Affordability},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2025},
  doi = {10.1002/cpt.3579}
}
Start for free →